Myriad Genetics reported -3600000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Accelerate Diagnostics AXDX:US -17803000 3.62M
Agilent A:US $ 465M 86M
Biocept BIOC:US $ -2.77M 0.08M
Danaher DHR:US $ 2549M 12.71M
Exact Sciences EXAS:US $ -167.81M 15.14M
Fluidigm FLDM:US $ -65.15M 11.71M
Illumina ILMN:US $ 121M 69M
Nanostring Technologies NSTG:US $ 39.06M 78.47M
Orasure Technologies OSUR:US $ -19.97M 3.94M
Pacific Biosciences Of California PACB:US $ -71.39M 10.1M
Quest Diagnostics DGX:US $ 370M 123M
Veracyte VCYT:US $ -9.65M 4.82M